Reports Q2 revenue $70.801M, consensus $64.07M. “This divestiture is transformational for both the Blade Passenger business and Blade’s Medical division, that will remain a standalone publicly traded company. We strongly believe that this is the best path forward to create long term value for all stakeholders including employees, customers, partners and shareholders,” said Rob Wiesenthal, Blade’s Chief Executive Officer. “Blade’s Medical business has grown from 12% of revenue in 2020 to over 60% of revenue over the last year.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLDE:
- Cathie Wood’s Manic Monday Moves: Buys AMD and Nvidia, Sells Roblox and Blade Air Mobility
- M&A News: Joby Aviation Stock Soars as Blade Deal Fast-Tracks Air Taxi Rollout
- Tesla grants Musk big payout, Wayfair reports Q2 beat: Morning Buzz
- Morning Movers: Wayfair surges following second quarter results
- Blade Air Mobility Sells Passenger Division to Joby